Hôpital Pitié-Salpêtrière, AP-HP
Paris, 75013, France
NCT Number: NCT02840669
Friedreich's ataxia (FA) is an autosomal recessive disease with an incidence of 1/50,000 in the Caucasian population. The main manifestations of FA are progressive sensory and cerebellar ataxia and cardiomyopathy (CM). It is the most common form of inherited ataxia. A severe CM affects ~60% of FA patients, mostly young adults, and leads to cardiac failure then death. Currently, no therapy can change the course of this severe cardiomyopathy.
This study is designed to characterize the cardiac manifestations of FA using cardiac magnetic resonance (CMR), echocardiography, serum cardiac biomarkers and evaluation of fatigue severity, in the context of the neurological disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Paris, 75013, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
(Friedreich's Ataxia):
Exclusion criteria
(Friedreich's Ataxia):
Inclusion criteria
(Healthy Volunteers):
Exclusion criteria
(Healthy Volunteers):
Time frame: 2 hours
Time frame: 2 hours
Time frame: 2 hours
Time frame: 30 minutes
Time frame: 30 minutes
Adverum Biotechnologies, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02316314
Ataxia, Brain Diseases
New York, United States
View Trial DetailsNCT02069509
Brain Diseases, Central Nervous System Diseases
Innsbruck, Austria
View Trial DetailsNCT02415127
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial DetailsNCT02593773
Brain Diseases, Central Nervous System Diseases
Los Angeles, California, United States
View Trial Details